📣 ADDS 2027 Save the Date!
We hope you'll join us for our 5th meeting, ADDS 2027, taking place Feb 8-10, 2027 in Atlanta, GA.
Subscribe to Receive Updates
Solutions
Digital Health Technology
New
Ametris Connect™ Platform
Sensors and Wearables
Patient Engagement
Algorithm Marketplace
Digital Outcomes and Biomarkers
Sleep
Physical Activity
Gait and Mobility
Vital Signs
Cardinal Symptoms
Cough Detection
CRS Adverse Events
Trials Enablement
Adherence Monitoring
Digital Health Operations
Data Analytics & Regulatory Science Services
CentrePoint® Platform
ActiGraph LEAP®
Usability Evaluation Program
CentrePoint® Insight Watch
Therapeutic Expertise
Cardiology
New
Dermatology
Obesity
Oncology
Respiratory
Rheumatology and Immunology
Neurology
Movement Disorders
Neuromuscular Disorders
Sleep Disorders
New
Evidence
DECODE
New
DECODE CRS
DECODE Nocturnal Scratch
DECODE Obesity
Publications
Resources
Patient Report Library
Ametris Blog
Digital Endpoint Guides
Webinars
News
Events
Academic Research
Population Health
CentrePoint®
ActiLife®
Wearable Devices
ActiGraph LEAP®
CentrePoint® Insight Watch
ActiGraph wGT3X-BT
Academic Store
Grant Toolkit
New
Dataset Library
New
Company
About Us
A Signant Health Company
Team
Partnerships
Solutions
Digital Health Technology
New
Ametris Connect™ Platform
Sensors and Wearables
Patient Engagement
Algorithm Marketplace
Digital Outcomes and Biomarkers
Sleep
Physical Activity
Gait and Mobility
Vital Signs
Cardinal Symptoms
Cough Detection
CRS Adverse Events
Trials Enablement
Adherence Monitoring
Digital Health Operations
Data Analytics & Regulatory Science Services
CentrePoint® Platform
ActiGraph LEAP®
Usability Evaluation Program
CentrePoint® Insight Watch
Therapeutic Expertise
Cardiology
New
Dermatology
Obesity
Oncology
Respiratory
Rheumatology and Immunology
Neurology
Movement Disorders
Neuromuscular Disorders
Sleep Disorders
New
Evidence
DECODE
New
DECODE CRS
DECODE Nocturnal Scratch
DECODE Obesity
Publications
Resources
Patient Report Library
Ametris Blog
Digital Endpoint Guides
Webinars
News
Events
Academic Research
Population Health
CentrePoint®
ActiLife®
Wearable Devices
ActiGraph LEAP®
CentrePoint® Insight Watch
ActiGraph wGT3X-BT
Academic Store
Grant Toolkit
New
Dataset Library
New
Company
About Us
A Signant Health Company
Team
Partnerships
Contact us!
Contact Us
SEARCH
Ametris
Blog
Stay up to date with in-depth expert insights, latest trends, and thought leadership in our industry-focused blog, designed to keep you informed and advancing not just research, but global health outcomes.
Posts about
digital health technology
neurology
,
regulated clinical trials
,
neuromuscular disorders
,
pediatric research
,
digital health technology
Novel Digital Measures for Tracking Disease Progression in Duchenne Muscular Dystrophy Beyond Loss of Ambulation
Duchenne muscular dystrophy (DMD) is a serious genetic disorder that causes muscles to weaken over...
5 Minute Read
Read More
actigraphy
,
ActiGraph
,
heart failure
,
digital health technology
,
ActiGraph LEAP
,
Cardiology
Building Patient-Centric Cardiovascular Endpoints with Continuous Digital Measures
Conventional cardiovascular trial endpoints — mortality, major adverse cardiac events,...
3 Minute Read
Read More
actigraphy
,
ActiGraph
,
heart failure
,
physical activity
,
mobility
,
digital health technology
,
ActiGraph LEAP
Measures in Motion: Demonstrating Analytical Validation Results at ICAMPAM 2026
Wearable sensors are becoming central to how clinical researchers and drug developers measure how...
4 Minute Read
Read More
actigraphy
,
ActiGraph
,
physical activity
,
digital health technology
,
ActiGraph LEAP
,
evidence generation
Device Comparability and Data Compatibility Across ActiGraph Generations
As the digital health landscape continues to evolve, researchers are increasingly looking to...
1 Minute Read
Read More
neurology
,
regulated clinical trials
,
physical activity
,
Obesity
,
Immunotherapy
,
digital health technology
,
evidence generation
,
movement disorder
Advancing Huntington’s Disease Clinical Trials: How Digital Health Technologies Can Transform Drug Development
Insights from the Ametris Digital Data Summit (ADDS) 2026 Pre-Conference Workshop At the annual...
5 Minute Read
Read More
neurology
,
ALS
,
algorithms
,
Data Science
,
vital signs
,
neuromuscular disorders
,
patient voice
,
AI
,
digital health technology
,
MND
,
ADDS
Sharing Outcomes from the ALS Workshop at ADDS 2025 at the NEALS Conference
Since 2022, the Ametris Digital Data Summit (ADDS) has brought together researchers and experts...
2 Minute Read
Read More
wear compliance
,
fit-for-purpose
,
adherence
,
digital health technology
,
data collection
,
patient engagement
,
EDC integration
Aligning Wearable Data Collection with Visit Schedules Through EDC Integration
In my last blog, Wearable Data Is Only Useful If It’s There: Helping You Collect Your Study Data, I...
4 Minute Read
Read More
wear compliance
,
fit-for-purpose
,
adherence
,
digital health technology
,
data collection
,
patient engagement
Wearable Data is Only Useful if It’s There: Helping You Collect Your Study Data
While our company name has recently changed to Ametris, our obsession with collecting high-quality...
3 Minute Read
Read More
clinical research
,
medical-grade wearables
,
ActiGraph
,
digital transformation
,
digital health technology
,
Ametris
Embracing Our Next Chapter: ActiGraph is Now Ametris
I’m proud to share a huge new milestone in our journey: ActiGraph has officially rebranded to...
2 Minute Read
Read More
oncology
,
algorithms
,
Data Science
,
vital signs
,
AI
,
Immunotherapy
,
Cytokine Release Syndrome
,
digital health technology
The Pathway to a Digital Health Solution for Cytokine Release Syndrome Detection and Prediction
In this article, I’m excited to dive into the opportunities and challenges in the field of ...
5 Minute Read
Read More
clinical research
,
medical-grade wearables
,
ActiGraph
,
digital transformation
,
digital health technology
,
Ametris
Embracing Our Next Chapter: ActiGraph is Now Ametris
I’m proud to share a huge new milestone in our journey: ActiGraph has officially rebranded to...
2 Minute Read
Read More